Mission & Vision

We believe you.

HerstasisTM is enabling a step-change in the Standard of Care and Quality of Life of women experiencing debilitating and distressing symptoms of the menopausal transition.

Things will get better.

Our integrated women’s health platform will give diverse women the tools to learn, communicate and take action on menopausal symptoms that are impacting their life, and those around them.

There is something you can do about it.

Female,Diverse,Faces,Of,Different,Ethnicity,Seamless,Pattern.,Women,Empowerment

Women

We believe women when they tell us about their symptoms, and we believe everyone experiences perimenopause differently.

Together

We believe that women’s health and gender equity can only be improved if we serve and include a broad group of women from many cultures, languages and abilities.

Education

We believe that women deserve education along with affordable, accurate, useful tools to take control of their own personal menopausal health.

Science

We believe that women deserve to be included in clinical trials, with fewer exclusions, to deliver better diagnostics and evidence-based symptom management therapeutics.

Solving our own problems.

HerstasisTM is building a bridge between perimenopausal women, health care providers and researchers through scientific knowledge translation, low-cost point-of-care urinalysis, and the development of a world-class endocrine-based, longitudinal women’s health model.

Our goal is to reach millions of women to help them understand what is happening with their body and their mind, and to ultimately help them have a healthier, more peaceful menopause transition.

Our Team

Our team is comprised of scientists, engineers, business professionals and clinical researchers working together to create a platform for women to manage their often devastating menopause symptoms and feel more in control of their life.

Jennifer Thompson

CEO & Founder

Jennifer Thompson

CEO & Founder
Jennifer is an expert in the development and commercialization of applied science technologies for impact markets, a hands-on Angel investor, and a governance nut. In addition to her role as Founder & CEO of Herstasis Health, she is currently the Executive Board Chair of CuePath Innovation, and was previously Director and Compensation Committee Chair of Acuva Technologies, and Director and COO of Cryologistics Refrigeration Technologies. She has served as Board Secretary for Enwave Corporation, a TSX-Venture listed company, and Executive VP for Enterra Feed Corporation. In the non-profit realm, Jennifer currently serves as a Director and Chair, Nominations & Governance Committee of the Elizabeth Fry Society of Greater Vancouver, a Canadian NSERC-I2I Grant Funding Review Committee member, and is a member of the UNICEF Canada Women UNlimited philanthropy program.

Dr. Jenna Dunlop

Content Strategy + Knowledge Translation

Dr. Jenna Dunlop

Content Strategy + Knowledge Translation
Dr. Jenna Dunlop Jenna completed her undergraduate education at the University of Toronto with a double major in Psychology and Anthropology. She followed this with a PhD in Evolutionary Biology (Zoology) and finally, an MBA, both from York University. Jenna started her career writing and editing high school science and math textbooks, specializing in Biology and Chemistry. She also worked at York University and George Brown College teaching Natural Science and Biology courses. Jenna has extensive experience in policy and technology development working first as a Senior Policy Advisor at the Ontario Ministry of Research and Innovation and then moving into climate change policy and developing Durham Region’s Climate Change Strategy. She then heard the mountains calling and moved West to take on positions as the Manager of Climate Change Policy and then Manager of Environmental Policy at CAPP, the Canadian Association of Petroleum Producers, and then as Director of Land at COSIA, Canada’s Oil Sands Innovation Alliance. Jenna recently left the corporate world to return to writing full time. Her focus has been writing, editing and plain language/science translation for a diverse range of organizations including the Canadian Energy Research Institute and the Oil Sands Monitoring Program.

Dr. Kristina Sachs-Barrable

Regulatory Strategy + Clinical Trials

Dr. Kristina Sachs-Barrable

Regulatory Strategy + Clinical Trials
Dr. Kristina Sachs-Barrable has more than 25 years of experience in clinical and pre-clinical research working with academic and industrial partners as well as Health Care Providers. She has made several scientific discoveries that led to successful grant applications, three patents and numerous publications. Kristina holds a PhD in Biochemistry/Biophysics from Humboldt University in Berlin. She did a postdoctoral fellowship at the University of California, Berkeley in Neuroscience and subsequently did research and taught in the Faculty of Pharmaceutical Sciences at UBC for more than a decade. She has formal training and experience in Regulatory Affairs, Knowledge Translation and Project Management. She is passionate about turning scientific evidence into improved health outcomes and better quality of life and is very excited to work at Herstasis Health to address women’s health issues.

Dr. Kathryn Fink

Chief Scientific Officer

Dr. Kathryn Fink

Chief Scientific Officer
Kathryn holds a Ph.D. in Bioengineering from the University of California, Berkeley as well as a B.S. in Biomedical Engineering from the University of Southern California. During her time in academia, she was recognized as a Siebel Scholar, a National Science Foundation Graduate Research Fellow and an ARCS Scholar. Her experience in research and development has spanned nearly two decades at all levels of the research process, ranging from conducting plant viability assays as a lab assistant at the United States Department of Agriculture’s National Center for Genetic Resources Preservation; studying the fluid dynamics and heat transfer properties of the world’s lightest material at HRL Laboratories; and leading the design & development of a continuous glucose monitor for an angel-funded startup.

Jennifer Vander Zalm

Chief Technology Officer

Jennifer Vander Zalm

Chief Technology Officer
Jennifer graduated from the University of Victoria with a degree in computer engineering. She has 20 years experience in programming, design and validation in the field of high performance ASICs [application specific integrated circuits]. As a member of Broadcom’s high performance Ethernet network adapter team, Jenn most recently completed work on the 200 Gb products designed for high-performance virtualization, intelligent flow processing, secure data center connectivity, and machine learning. She now looks forward to the new challenges and application of devices in the personal health industry.  

Dr. Dee Brink

Knowledge Translation

Dr. Dee Brink

Knowledge Translation
As long as can remember I’ve been enchanted with plants and animals. I fell in love with aquatic life when our family spent holidays on the Jersey shore, and spent long hours nerdishly looking through my dad’s college microscope at the invisible world of micro- life. I did a BS in Biological science at Long Island University , an MS at UC Irvine in neural regeneration in the visual system of fish (more studies in sensory physiology), and then headed up the Northwest coast to University of Oregon, to finish my doctorate in a biophysical study of the electrical activity of the heart beat in moths. Along this wandering pathway I’ve taught courses in Physiology, Endocrinology, Neuroscience, and Evolution at Simon Fraser University, University of British Columbia, and North Island College.